Infosys vs Cognizant fight gets uglier! Why are the two big IT firms battling it out in the US? Explained

headlines4Top Stories8 months ago1.6K Views

[ad_1]

Infosys vs Cognizant fight gets uglier! Why are the two big IT firms battling it out in the US? Explained
The authorized battle revolves round TriZetto, a healthcare software program platform acquired by Cognizant in 2014.

The Infosys vs Cognizant fight is getting uglier by the day. But why are the two IT sector giants locked in a battle or staff in the US? In an ongoing authorized dispute between the two IT corporations, Infosys has recognized two senior Cognizant officers, Americas President Surya Gummadi and Chief People Officer Kathryn Diaz, as main figures in what it describes as anti-competitive practices concentrating on its US healthcare platform, based on an ET report. The allegations have been detailed in a joint courtroom submission, highlighting issues over aggressive practices and mental property.

Infosys vs Cognizant: What’s the fight about?

  • The dispute centres on TriZetto, a healthcare software program system that Cognizant bought in 2014, which allegedly competes with Infosys’s Helix platform.
  • According to the report, Infosys has alleged that former Helix chief and present Cognizant CEO Ravi Kumar S, who departed Infosys in October 2022, intentionally postponed Helix’s introduction and subsequently recruited important personnel after becoming a member of Cognizant in January 2023, thereby undermining the platform’s potential success.
  • The report says that the dispute started in August 2024 when Cognizant’s TriZetto launched authorized proceedings in opposition to Infosys in a Texas federal courtroom, claiming that Infosys had improperly utilised confidential data obtained by non-disclosure agreements to develop a rival resolution.
  • Subsequently, Infosys filed countercharges in January 2025, asserting that Cognizant had intentionally recruited high-ranking employees members and utilised proprietary data to compromise Helix.
  • Infosys alleged that these actions have been components of a complete plan to limit competitors inside the American healthcare IT sector, the report provides.

Regarding management positions, Infosys’s current courtroom paperwork declare that Gummadi and Diaz performed vital roles in Cognizant’s technique to hinder Helix’s market introduction. The firm asserted that these senior appointments have been strategically deliberate to decrease Infosys’s market place.Also Read | ‘Maintain work-life steadiness’: Infosys asks employees to not work time beyond regulation; Narayana Murthy had spoken of 70-hour work week conceptAdditionally, Infosys claimed that Ravi Kumar’s earlier oversight of Helix offered Cognizant with unwarranted advantages after his transition to the CEO place.

What Cognizant Has Said

Cognizant dismissed Infosys’s counter allegations and sought their dismissal in courtroom, stating that the accusations have been unsupported by proof and contained improper market definitions.“Infosys was caught red-handed misappropriating TriZetto trade secrets that Infosys originally had access to through non-disclosure and access agreements (NDAAs),” Cognizant mentioned in its response, based on the ET report.Additionally, Cognizant acknowledged that Infosys had prevented an audit that might have confirmed the unauthorised entry to confidential data.Also Read | It’s a primary! Infosys launches money reward coverage for workers who assist with hiring; employees to earn Rs 700 per interview

Infosys’ Allegations of Monopoly

Previously, Infosys levelled accusations in opposition to Cognizant, claiming it misused its dominant place by curbing manufacturing and elevating costs, which allegedly broken consumer advantages and stifled market competitors.“Monopoly power may be pled directly—through allegations of supra-competitive prices and restricted output—or inferred from the structure and composition of the relevant market,” Infosys acknowledged in its courtroom submitting.In its defence, Cognizant contested Infosys’s monopoly claims, stating that holding 65% market share alone doesn’t set up monopolistic management, and criticised Infosys for failing to determine clear market parameters.This dispute emerges as Indian IT corporations encounter diminishing progress charges and heightened rivalry in the American market.



[ad_2]

0 Votes: 0 Upvotes, 0 Downvotes (0 Points)

Follow
Loading

Signing-in 3 seconds...

Signing-up 3 seconds...